XW04357Introduction of Narsoplimab Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 7

XW04357 is the ICD-10-PCS code for a introduction procedure on the central vein using a percutaneous approach with narsoplimab monoclonal antibody (qualifier: new technology group 7). In ICD-10-PCS, introduction means putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

For a different body part, codes include XW03357 (peripheral vein).

With a different device, use XW043A7 (ciltacabtagene autoleucel), XW043C7 (recombinant human bone morphogenetic protein-2 with collagen scaffold), XW043G7 (vancomycin hydrochloride and tobramycin sulfate anti-infective, temporary irrigation spacer system), XW043H7 (paclitaxel-coated balloon technology, one balloon), XW043J7 (paclitaxel-coated balloon technology, two balloons), XW043K7 (paclitaxel-coated balloon technology, three balloons) and 3 more.

It doesn't appear in the MS-DRG procedure index, so on its own it doesn't change the DRG assignment.

It was added in FY2022, effective October 1, 2021.